Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptors

PPAR Research

Volumn , Issue , 2013, Pages

  Mandard, Stéphane ^a   Patsouris, David ^b,c  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b UNIVERSITÉ LYON 1   (France)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; 3 [(4 ANILINO 2 METHOXYPHENYL)SULFAMOYL] 2 THENOIC ACID METHYL ESTER; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; [4 [2 (3 FLUORO 4 TRIFLUOROMETHYLPHENYL) 4 METHYL 5 THIAZOLYLMETHYLTHIO] 2 METHYLPHENOXY]ACETIC ACID; ANTILIPEMIC AGENT; ARHALOFENATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PIOGLITAZONE; RECEPTOR BLOCKING AGENT; ROSIGLITAZONE;

ADIPOSE TISSUE; CARDITIS; ENTERITIS; HEPATITIS; HUMAN; INFLAMMATION; INNATE IMMUNITY; LIVESTOCK; MACROPHAGE; MAMMAL; MASTITIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; REVIEW; SANITATION; SPECIES; SWINE;

EID: 84876577003     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2013/613864     Document Type: Review

References (262)

1. Kersten S., Mandard S., Escher P., Gonzalez F. J., Tafuri S., Desvergne B., Wahli W., The peroxisome proliferator-activated receptor α regulates amino acid metabolism. FASEB Journal 2001 15 11 1971 1978 2-s2.0-0034842626 10.1096/fj.01-0147com (Pubitemid 32848801)
2. Nadra K., Anghel S. I., Joye E., Tan N. S., Basu-Modak S., Trono D., Wahli W., Desvergne B., Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor β / δ Molecular and Cellular Biology 2006 26 8 3266 3281 2-s2.0-33645802802 10.1128/MCB.26.8.3266-3281.2006
3. Tan N. S., Icre G., Montagner A., Bordier-Ten Heggeler B., Wahli W., Michalik L., The nuclear hormone receptor peroxisome proliferator-activated receptor β / δ potentiates cell chemotactism, polarization, and migration. Molecular and Cellular Biology 2007 27 20 7161 7175 2-s2.0-35148898673 10.1128/MCB.00436-07 (Pubitemid 47549752)
4. Genolet R., Kersten S., Braissant O., Mandard S., Tan N. S., Bucher P., Desvergne B., Michalik L., Wahli W., Promoter rearrangements cause species-specific hepatic regulation of the glyoxylate reductase/hydroxypyruvate reductase gene by the peroxisome proliferator-activated receptor α Journal of Biological Chemistry 2005 280 25 24143 24152 2-s2.0-21244501406 10.1074/jbc.M502649200 (Pubitemid 40884902)
5. Mandard S., Stienstra R., Escher P., Tan N. S., Kim I., Gonzalez F. J., Wahli W., Desvergne B., Müller M., Kersten S., Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors. Cellular and Molecular Life Sciences 2007 64 9 1145 1157 2-s2.0-34247630647 10.1007/s00018-007-7006-1 (Pubitemid 46684553)
6. Chamouton J., Hansmannel F., Bonzo J. A., Clémencet M. C., Chevillard G., Battle M., Martin P., Pineau T., Duncan S., Gonzalez F. J., Latruffe N., Mandard S., Nicolas-Francés V., The peroxisomal 3-keto-acyl-CoA thiolase B gene expression is under the dual control of PPAR and HNF4 in the liver. PPAR Research 2010 2010 17 2-s2.0-79955104006 10.1155/2010/352957 352957
7. IJpenberg A., Jeannin E., Wahli W., Desvergne B., Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element. Journal of Biological Chemistry 1997 272 32 20108 20117 2-s2.0-0030818756 10.1074/jbc.272.32.20108 (Pubitemid 27340117)
8. Di-Po N., Tan N. S., Michalik L., Wahli W., Desvergne B., Antiapoptotic role of PPAR β in keratinocytes via transcriptional control of the Akt1 signaling pathway. Molecular Cell 2002 10 4 721 733 2-s2.0-0036771764 10.1016/S1097-2765(02)00646-9 (Pubitemid 35335629)
9. Tan N. S., Michalik L., Desvergne B., Wahli W., Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes. Journal of Steroid Biochemistry and Molecular Biology 2005 93 2-5 99 105 2-s2.0-18044396753 10.1016/j.jsbmb.2004.12.025 (Pubitemid 40602481)
10. Tan N. S., Michalik L., Noy N., Yasmin R., Pacot C., Heim M., Flühmann B., Desvergne B., Wahli W., Critical roles of PPAR β / δ in keratinocyte response to inflammation. Genes and Development 2001 15 24 3263 3277 2-s2.0-0035893364 10.1101/gad.207501 (Pubitemid 34008192)
11. Devchand P. R., Keller H., Peters J. M., Vazquez M., Gonzalez F. J., Wahli W., The PPAR α -leukotriene B4 pathway to inflammation control. Nature 1996 384 6604 39 43 2-s2.0-0029661982 10.1038/384039a0 (Pubitemid 26374579)
12. Issemann I., Green S., Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990 347 6294 645 650 2-s2.0-0025132245 10.1038/347645a0 (Pubitemid 20356241)
13. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., Wahli W., Control of the peroxisomal β -oxidation pathway by a novel family of nuclear hormone receptors. Cell 1992 68 5 879 887 2-s2.0-0026517010 10.1016/0092-8674(92)90031-7
14. Schmidt A., Endo N., Rutledge S. J., Vogel R., Shinar D., Rodan G. A., Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Molecular Endocrinology 1992 6 10 1634 1641 2-s2.0-0026785388 10.1210/me.6.10.1634
15. Amri E. Z., Bonino F., Ailhaud G., Abumrad N. A., Grimaldi P. A., Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. Journal of Biological Chemistry 1995 270 5 2367 2371 2-s2.0-0028909362 10.1074/jbc.270.5.2367
16. Zhu Y., Alvares K., Huang Q., Rao M. S., Reddy J. K., Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. Journal of Biological Chemistry 1993 268 36 26817 26820 2-s2.0-0027749599 (Pubitemid 24006385)
17. Chen F., Law S. W., O'Malley B. W., Identification of two mPPAR related receptors and evidence for the existence of five subfamily members. Biochemical and Biophysical Research Communications 1993 196 2 671 677 2-s2.0-0027504874 10.1006/bbrc.1993.2302 (Pubitemid 23337660)
18. Tontonoz P., Hu E., Graves R. A., Budavari A. I., Spiegelman B. M., mPPAR γ 2: tissue-specific regulator of an adipocyte enhancer. Genes and Development 1994 8 10 1224 1234 2-s2.0-0028180070
19. Nagasawa M., Ide T., Suzuki M., Tsunoda M., Akasaka Y., Okazaki T., Mochizuki T., Murakami K., Pharmacological characterization of a human-specific peroxisome proliferater-activated receptor α (PPAR α) agonist in dogs. Biochemical Pharmacology 2004 67 11 2057 2069 2-s2.0-2342475664 10.1016/j.bcp.2004.02.019 (Pubitemid 38595487)
20. Auboeuf D., Rieusset J., Fajas L., Vallier P., Frering V., Riou J. P., Staels B., Auwerx J., Laville M., Vidal H., Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor- α in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes 1997 46 8 1319 1327 2-s2.0-0030747895 (Pubitemid 27315281)
21. Aperlo C., cDNA cloning and characterization of the transcriptional activities of the hamster peroxisome proliferator-activated receptor haPPAR γ Gene 1995 162 2 297 302 2-s2.0-0029121281 10.1016/0378-1119(95)00196-D
22. Sher T., Yi H. F., McBride O. W., Gonzalez F. J., cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 1993 32 21 5598 5604 2-s2.0-0027191040 (Pubitemid 23178525)
23. Diot C., Douaire M., Characterization of a cDNA sequence encoding the peroxisome proliferator activated receptor α in the chicken. Poultry Science 1999 78 8 1198 1202 2-s2.0-0033173081 (Pubitemid 129555937)
24. Kliewer S. A., Forman B. M., Blumberg B., Ong E. S., Borgmeyer U., Mangelsdorf D. J., Umesono K., Evans R. M., Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proceedings of the National Academy of Sciences of the United States of America 1994 91 15 7355 7359 2-s2.0-0028321529 10.1073/pnas.91.15.7355 (Pubitemid 24226862)
25. Ibabe A., Grabenbauer M., Baumgart E., Fahimi D. H., Cajaraville M. P., Expression of peroxisome proliferator-activated receptors in zebrafish (Danio rerio). Histochemistry and Cell Biology 2002 118 3 231 239 2-s2.0-0036379193
26. Ibabe A., Grabenbauer M., Baumgart E., Völkl A., Fahimi H. D., Cajaraville M. P., Expression of peroxisome proliferator-activated receptors in the liver of gray mullet (Mugil cephalus). Acta Histochemica 2004 106 1 11 19 2-s2.0-1442276287 10.1016/j.acthis.2003.09.002 (Pubitemid 38280210)
27. Leaver M. J., Boukouvala E., Antonopoulou E., Diez A., Favre-Krey L., Tariq Ezaz M., Bautista J. M., Tocher D. R., Krey G., Three peroxisome proliferator-activated receptor isotypes from each of two species of marine fish. Endocrinology 2005 146 7 3150 3162 2-s2.0-22144488828 10.1210/en.2004-1638 (Pubitemid 41007050)
28. Boukouvala E., Antonopoulou E., Favre-Krey L., Diez A., Bautista J. M., Leaver M. J., Tocher D. R., Krey G., Molecular characterization of three peroxisome proliferator-activated receptors from the sea bass (Dicentrarchus labrax). Lipids 2004 39 11 1085 1092 2-s2.0-12344320174 10.1007/s11745-004-1334- z (Pubitemid 40129051)
29. Leaver M. J., Ezaz M. T., Fontagne S., Tocher D. R., Boukouvala E., Krey G., Multiple peroxisome proliferator-activated receptor β subtypes from Atlantic salmon (Salmo salar). Journal of Molecular Endocrinology 2007 38 3-4 391 400 2-s2.0-34248222235 10.1677/JME-06-0043 (Pubitemid 46723255)
30. Tugwood J. D., Holden P. R., James N. H., Prince R. A., Roberts R. A., A peroxisome proliferator-activated receptor-alpha (PPAR α) cDNA cloned from guinea-pig liver encodes a protein wit h similar properties to the mouse PPAR α: implications for species differences in responses to peroxisome proliferators. Archives of Toxicology 1998 72 3 169 177 2-s2.0-0031915653 10.1007/s002040050483 (Pubitemid 28070165)
31. Tsai M. L., Chen H. Y., Tseng M. C., Chang R. C., Cloning of peroxisome proliferators activated receptors in the cobia (Rachycentron canadum) and their expression at different life-cycle stages under cage aquaculture. Gene 2008 425 1-2 69 78 2-s2.0-53149109668 10.1016/j.gene.2008.08.004
32. Nishii N., Takasu M., Soe O. K., Maeda S., Ohba Y., Inoue-Murayama M., Kitagawa H., Cloning, expression and investigation for polymorphisms of canine peroxisome proliferator-activated receptors. Comparative Biochemistry and Physiology B 2007 147 4 690 697 2-s2.0-34250327398 10.1016/j.cbpb.2007.04.011 (Pubitemid 46921000)
33. He S., Liang X.-F., Qu C.-M., Huang W., Zhang W.-B., Mai K.-S., Identification, organ expression and ligand-dependent expression levels of peroxisome proliferator activated receptors in grass carp (Ctenopharyngodon idella). Comparative Biochemistry and Physiology 2012 155 2 381 388 10.1016/j.cbpc.2011.10.008
34. Meng H., Li H., Wang X. Y., Cloning and sequence analysis of cDNA encoding PPAR from goose. Yi Chuan 2004 26 4 469 472 2-s2.0-33645528016
35. Mano H., Kimura C., Fujisawa Y., Kameda T., Watanabe-Mano M., Kaneko H., Kaneda T., Hakeda Y., Kumegawa M., Cloning and function of rabbit peroxisome proliferator-activated receptor δ / β in mature osteoclasts. Journal of Biological Chemistry 2000 275 11 8126 8132 2-s2.0-0034678061 10.1074/jbc.275.11.8126 (Pubitemid 30159727)
36. Grindflek E., Sundvold H., Klungland H., Lien S., Characterisation of porcine peroxisome proliferator-activated receptors γ 1 and γ 2: detection of breed and age differences in gene expression. Biochemical and Biophysical Research Communications 1998 249 3 713 718 2-s2.0-0032575580 10.1006/bbrc.1998.9212 (Pubitemid 28441905)
37. Lambe K. G., Tugwood J. D., A human peroxisome-proliferator-activated receptor- γ is activated by inducers of adipogenesis, including thiazalidinedione drugs. European Journal of Biochemistry 1996 239 1 1 7 2-s2.0-0029977518 (Pubitemid 26228133)
38. Omi T., Brenig B., Spilar S., Iwamoto S., Stranzinger G., Neuenschwander S., Identification and characterization of novel peroxisome proliferator- activated receptor-gamma (PPAR- γ) transcriptional variants in pig and human. Journal of Animal Breeding and Genetics, Supplement 2005 122 1 45 53 2-s2.0-16844377217 (Pubitemid 40482953)
39. Zhou J., Wilson K. M., Medh J. D., Genetic analysis of four novel peroxisome proliferator activated receptor- γ splice variants in monkey macrophages. Biochemical and Biophysical Research Communications 2002 293 1 274 283 2-s2.0-0036290825 10.1016/S0006-291X(02)00138-9 (Pubitemid 34694203)
40. Sundvold H., Grindflek E., Lien S., Tissue distribution of porcine peroxisome proliferator-activated receptor α: detection of an alternatively spliced mRNA. Gene 2001 273 1 105 113 2-s2.0-0035948577 10.1016/S0378-1119(01)00562-5 (Pubitemid 32718732)
41. Hanselman J. C., Vartanian M. V., Koester B. P., Gray S. A., Essenburg A. D., Rea T. J., Bisgaier C. L., Pape M. E., Expression of the mRNA encoding truncated PPAR α does not correlate with hepatic insensitivity to peroxisome proliferators. Molecular and Cellular Biochemistry 2001 217 1-2 91 97 2-s2.0-0035119895 10.1023/A:1007248007372 (Pubitemid 32184460)
42. Houseknecht K. L., Bidwell C. A., Portocarrero C. P., Spurlock M. E., Expression and cDNA cloning of porcine peroxisome proliferator-activated receptor gamma (PPAR γ). Gene 1998 225 1-2 89 96 2-s2.0-0032576578 10.1016/S0378-1119(98)00533-2 (Pubitemid 29030438)
43. Winegar D. A., Brown P. J., Wilkison W. O., Lewis M. C., Ott R. J., Tong W. Q., Brown H. R., Lehmann J. M., Kliewer S. A., Plunket K. D., Way J. M., Bodkin N. L., Hansen B. C., Effects of fenofibrate on lipid parameters in obese rhesus monkeys. Journal of Lipid Research 2001 42 10 1543 1551 2-s2.0-0034753632 (Pubitemid 33020086)
44. Escriva H., Safi R., Hänni C., Langlois M. C., Saumitou-Laprade P., Stehelin D., Capron A., Pierce R., Laudet V., Ligand binding was acquired during evolution of nuclear receptors. Proceedings of the National Academy of Sciences of the United States of America 1997 94 13 6803 6808 2-s2.0-0030962710 10.1073/pnas.94.13.6803 (Pubitemid 27281945)
45. Oku H., Umino T., Molecular characterization of peroxisome proliferator-activated receptors (PPARs) and their gene expression in the differentiating adipocytes of red sea bream Pagrus major. Comparative Biochemistry and Physiology B 2008 151 3 268 277 2-s2.0-52149124641 10.1016/j.cbpb.2008.07.007
46. Eddy S. F., Morin P., Storey K. B., Cloning and expression of PPAR γ and PGC-1 α from the hibernating ground squirrel, Spermophilus tridecemlineatus. Molecular and Cellular Biochemistry 2005 269 1 175 182 2-s2.0-14244258928 10.1007/s11010-005-3459-4 (Pubitemid 40287815)
47. Greene M. E., Blumberg B., McBride O. W., Yi H. F., Kronquist K., Kwan K., Hsieh L., Greene G., Nimer S. D., Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expression 1995 4 4-5 281 299 2-s2.0-0029152375
48. Raingeard D., Cancio I., Cajaraville M. P., Cloning and expression pattern of peroxisome proliferator-activated receptor α in the thicklip grey mullet Chelon labrosus. Marine Environmental Research 2006 62 1 S113 S117 2-s2.0-33744988368 10.1016/j.marenvres.2006.04.009 (Pubitemid 43867711)
49. Chen Y., Jimenez A. R., Medh J. D., Identification and regulation of novel PPAR- γ splice variants in human THP-1 macrophages. Biochimica et Biophysica Acta 2006 1759 1-2 32 43 2-s2.0-33646480204 10.1016/j.bbaexp.2006.01. 005
50. Girroir E. E., Hollingshead H. E., He P., Zhu B., Perdew G. H., Peters J. M., Quantitative expression patterns of peroxisome proliferator-activated receptor- β / δ (PPAR β / δ) protein in mice. Biochemical and Biophysical Research Communications 2008 371 3 456 461 2-s2.0-43549113326 10.1016/j.bbrc.2008.04.086
51. Takada I., Kobayashi M., Takada I., Structural features and transcriptional activity of chicken PPARs (α β and γ). PPAR Research 2013 2013 7 186312 10.1155/2013/186312
52. Feige J. N., Gelman L., Tudor C., Engelborghs Y., Wahli W., Desvergne B., Fluorescence imaging reveals the nuclear behavior of peroxisome proliferator-activated receptor/retinoid X receptor heterodimers in the absence and presence of ligand. Journal of Biological Chemistry 2005 280 18 17880 17890 2-s2.0-23644439144 10.1074/jbc.M500786200 (Pubitemid 41389029)
53. IJpenberg A., Jeannin E., Wahli W., Desvergne B., Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element. Journal of Biological Chemistry 1997 272 32 20108 20117 2-s2.0-0030818756 10.1074/jbc.272.32.20108 (Pubitemid 27340117)
54. Mandard S., Zandbergen F., Nguan S. T., Escher P., Patsouris D., Koenig W., Kleemann R., Bakker A., Veenman F., Wahli W., Müller M., Kersten S., The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. Journal of Biological Chemistry 2004 279 33 34411 34420 2-s2.0-4544274752 10.1074/jbc.M403058200 (Pubitemid 39318067)
55. Helledie T., Grøntved L., Jensen S. S., Kiilerich P., Rietveld L., Albrektsen T., Boysen M. S., Nøhr J., Larsen L. K., Fleckner J., Stunnenberg H. G., Kristiansen K., Mandrup S., The gene encoding the acyl-CoA-binding protein is activated by peroxisome proliferator-activated receptor γ through an intronic response element functionally conserved between humans and rodents. Journal of Biological Chemistry 2002 277 30 26821 26830 2-s2.0-0037178868 10.1074/jbc.M111295200 (Pubitemid 34951688)
56. Degenhardt T., Matilainen M., Herzig K. H., Dunlop T. W., Carlberg C., The insulin-like growth factor-binding protein 1 gene is a primary target of peroxisome proliferator-activated receptors. Journal of Biological Chemistry 2006 281 51 39607 39619 2-s2.0-33845979155 10.1074/jbc.M605623200 (Pubitemid 46041920)
57. Nielsen R., Pedersen T. Å., Hagenbeek D., Moulos P., Siersbæk R., Megens E., Denissov S., Børgesen M., Francoijs K. J., Mandrup S., Stunnenberg H. G., Genome-wide profiling of PPAR γ:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes and Development 2008 22 21 2953 2967 2-s2.0-55749101777 10.1101/gad.501108
58. Boergesen M., Pedersen T. Å., Gross B., van Heeringen S. J., Hagenbeek D., Bindesbøll C., Caron S., Lalloyer F., Steffensen K. R., Nebb H. I., Gustafsson J., Stunnenberg H. G., Staels B., Mandrup S., Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor α in mouse liver reveals extensive sharing of binding sites. Molecular and Cellular Biology 2012 32 4 852 867 2-s2.0-84856777771 10.1128/MCB.06175-11
59. Auwerx J., Beato M., Chambon P., Cooney A., Dejean A., Dreyer C., Evans R. M., Gannon F., Giguere V., Gronemeyer H., Gustafsson J.-A., Laudet V., Lazar M. A., Mangelsdorf D. J., Millbrandt J., Milgrom E., Moore D. D., Parker K., Perimann T., Rosenfeld M. G., Samuels H., Schutz G., Sladek F. M., Stunnenberg H. G., Spedding M., Thummel C., Tsai M.-J., Umesono K., Vennstrom B., Wahli W., Weinberg C., Willson T. M., Yamamoto K., A unified nomenclature system for the nuclear receptor superfamily. Cell 1999 97 2 161 163 (Pubitemid 29194267)
60. Heinäniemi M., Uski J. O., Degenhardt T., Carlberg C., Meta-analysis of primary target genes of peroxisome proliferator-activated receptors. Genome Biology 2007 8 7, article R147 2-s2.0-39749108962 10.1186/gb-2007-8-7-r147 (Pubitemid 351903190)
61. Rakhshandehroo M., Hooiveld G., Müller M., Kersten S., Comparative analysis of gene regulation by the transcription factor PPAR α between mouse and human. PLoS ONE 2009 4 8 2-s2.0-69449086702 10.1371/journal.pone. 0006796 e6796
62. Tsuchida A., Yamauchi T., Takekawa S., Hada Y., Ito Y., Maki T., Kadowaki T., Peroxisome proliferator-activated receptor (PPAR) α activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPAR α PPAR γ and their combination. Diabetes 2005 54 12 3358 3370 2-s2.0-33644664433 10.2337/diabetes.54.12.3358 (Pubitemid 43334324)
63. Stienstra R., Mandard S., Patsouris D., Maass C., Kersten S., Müller M., Peroxisome proliferator-activated receptor α protects against obesity-induced hepatic inflammation. Endocrinology 2007 148 6 2753 2763 2-s2.0-34250821923 10.1210/en.2007-0014 (Pubitemid 46984788)
64. Toyoda T., Kamei Y., Kato H., Sugita S., Takeya M., Suganami T., Ogawa Y., Effect of peroxisome proliferator-activated receptor- α ligands in the interaction between adipocytes and macrophages in obese adipose tissue. Obesity 2008 16 6 1199 1207 2-s2.0-44649141518 10.1038/oby.2008.62 (Pubitemid 351771340)
65. Mandard S., Zandbergen F., Van Straten E., Wahli W., Kuipers F., Müller M., Kersten S., The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. Journal of Biological Chemistry 2006 281 2 934 944 2-s2.0-32644454369 10.1074/jbc.M506519200
66. Marathe C., Bradley M. N., Hong C., Chao L., Wilpitz D., Salazar J., Tontonoz P., Preserved glucose tolerance in high-fat-fed C57BL/6 mice transplanted with PPAR γ -/-, PPAR δ -/-, PPAR γ δ -/-, or LXR α β -/-bone marrow. Journal of Lipid Research 2009 50 2 214 224 2-s2.0-64749086158 10.1194/jlr.M800189-JLR200
67. Rodríguez-Calvo R., Serrano L., Coll T., Moullan N., Sánchez R. M., Merlos M., Palomer X., Laguna J. C., Michalik L., Wahli W., Vázquez-Carrera M., Activation of peroxisome proliferator-activated receptor β / δ inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor- B activity via extracellular signal-related kinase 1/2. Diabetes 2008 57 8 2149 2157 2-s2.0-50949105881 10.2337/db08-0176
68. Reilly S. M., Lee C. H., PPAR δ as a therapeutic target in metabolic disease. FEBS Letters 2008 582 1 26 31 2-s2.0-37349007681 10.1016/j.febslet.2007.11.040 (Pubitemid 350297247)
69. Hansen J. B., Zhang H., Rasmussen T. H., Petersen R. K., Flindt E. N., Kristiansen K., Peroxisome proliferator-activated receptor δ (PPAR δ)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling. Journal of Biological Chemistry 2001 276 5 3175 3182 2-s2.0-0035793577 10.1074/jbc.M005567200
70. Barak Y., Liao D., He W., Ong E. S., Nelson M. C., Olefsky J. M., Boland R., Evans R. M., Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America 2002 99 1 303 308 10.1073/pnas.012610299 (Pubitemid 34060358)
71. Barish G. D., Narkar V. A., Evans R. M., PPAR δ: a dagger in the heart of the metabolic syndrome. Journal of Clinical Investigation 2006 116 3 590 597 2-s2.0-33644645013 10.1172/JCI27955 (Pubitemid 43326863)
72. Lee C.-H., Olson P., Hevener A., Mehl I., Chong L.-W., Olefsky J. M., Gonzalez F. J., Ham J., Peters J. M., Evans R. M., PPAR δ regulates glucose metabolism and insulin sensitivity. Proceedings of the National Academy of Sciences of the United States of America 2006 103 9 3444 3449 10.1073/pnas.0511253103 (Pubitemid 43346488)
73. Tanaka T., Yamamoto J., Iwasaki S., Asaba H., Hamura H., Ikeda Y., Watanabe M., Magoori K., Ioka R. X., Tachibana K., Watanabe Y., Uchiyama Y., Sumi K., Iguchi H., Ito S., Doi T., Hamakubo T., Naito M., Auwerx J., Yanagisawa M., Kodama T., Sakai J., Activation of peroxisome proliferator-activated receptor δ induces fatty acid β -oxidation in skeletal muscle and attenuates metabolic syndrome. Proceedings of the National Academy of Sciences of the United States of America 2003 100 26 15924 15929 2-s2.0-9144271149 10.1073/pnas.0306981100 (Pubitemid 38021091)
74. Luquet S., Lopez-Soriano J., Holst D., Fredenrich A., Melki J., Rassoulzadegan M., Grimaldi P. A., Peroxisome proliferator-activated receptor δ controls muscle development and oxidative capability. FASEB Journal 2003 17 15 2299 2301 2-s2.0-0642303113 10.1096/fj.03-0269fje (Pubitemid 39561472)
75. Odegaard J. I., Ricardo-Gonzalez R. R., Red Eagle A., Vats D., Morel C. R., Goforth M. H., Subramanian V., Mukundan L., Ferrante A. W., Chawla A., Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metabolism 2008 7 6 496 507 2-s2.0-44349161098 10.1016/j.cmet.2008.04.003 (Pubitemid 351729205)
76. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L., Ferrante A. W., Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003 112 12 1796 1808 2-s2.0-0348230958 10.1172/JCI200319246 (Pubitemid 38063703)
77. Xu H., Barnes G. T., Yang Q., Tan G., Yang D., Chou C. J., Sole J., Nichols A., Ross J. S., Tartaglia L. A., Chen H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 2003 112 12 1821 1830 2-s2.0-9144223683 10.1172/JCI200319451 (Pubitemid 38063705)
78. Gordon S., Alternative activation of macrophages. Nature Reviews Immunology 2003 3 1 23 35 10.1038/nri978 (Pubitemid 37328697)
79. Kang K., Reilly S. M., Karabacak V., Gangl M. R., Fitzgerald K., Hatano B., Lee C. H., Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell Metabolism 2008 7 6 485 495 2-s2.0-44349112305 10.1016/j.cmet.2008.04.002 (Pubitemid 351729204)
80. Goossens G. H., The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiology and Behavior 2008 94 2 206 218 2-s2.0-42949088997 10.1016/j.physbeh.2007.10.010 (Pubitemid 351615418)
81. Sundvold H., Brzozowska A., Lien S., Characterisation of bovine peroxisome proliferator-activated receptors γ 1 and γ 2: genetic mapping and differential expression of the two isoforms. Biochemical and Biophysical Research Communications 1997 239 3 857 861 2-s2.0-0031590465 10.1006/bbrc.1997.7564 (Pubitemid 27504192)
82. Meng H., Li H., Zhao J. G., Gu Z. L., Differential expression of peroxisome proliferator-activated receptors alpha and gamma gene in various chicken tissues. Domestic Animal Endocrinology 2005 28 1 105 110 2-s2.0-11144331451 10.1016/j.domaniend.2004.05.003 (Pubitemid 40020320)
83. Escher P., Braissant O., Basu-Modak S., Michalik L., Wahli W., Desvergne B., Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 2001 142 10 4195 4202 2-s2.0-0034801882 10.1210/en.142.10.4195 (Pubitemid 32907045)
84. Zandbergen F., Mandard S., Escher P., Tan N. S., Patsouris D., Jatkoe T., Rojas-Caro S., Madore S., Wahli W., Tafuri S., Müller M., Kersten S., The G0/G1 switch gene 2 is a novel PPAR target gene. Biochemical Journal 2005 392 2 313 324 2-s2.0-29144451332 10.1042/BJ20050636 (Pubitemid 41796520)
85. Mukherjee R., Jow L., Croston G. E., Paterniti J. R., Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPAR γ 2 versus PPAR γ 1 and activation with retinoid X receptor agonists and antagonists. Journal of Biological Chemistry 1997 272 12 8071 8076 2-s2.0-0030951143 10.1074/jbc.272.12.8071 (Pubitemid 27137374)
86. Braissant O., Foufelle F., Scotto C., Dauça M., Wahli W., Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR- α-β and-γ in the adult rat. Endocrinology 1996 137 1 354 366 2-s2.0-0030047806 10.1210/en.137.1.354 (Pubitemid 26005011)
87. Tontonoz P., Hu E., Spiegelman B. M., Stimulation of adipogenesis in fibroblasts by PPAR γ 2, a lipid-activated transcription factor. Cell 1994 79 7 1147 1156 2-s2.0-0028641559
88. Brun R. P., Tontonoz P., Forman B. M., Ellis R., Chen J., Evans R. M., Spiegelman B. M., Differential activation of adipogenesis by multiple PPAR isoforms. Genes and Development 1996 10 8 974 984 2-s2.0-0029981772 (Pubitemid 26138708)
89. Imai T., Takakuwa R., Marchand S., Dentz E., Bornert J. M., Messaddeq N., Wendling O., Mark M., Desvergne B., Wahli W., Chambon P., Metzger D., Peroxisome proliferator-activated receptor γ is required in mature white and brown adipocytes for their survival in the mouse. Proceedings of the National Academy of Sciences of the United States of America 2004 101 13 4543 4547 2-s2.0-12144291563 10.1073/pnas.0400356101 (Pubitemid 38437447)
90. Chawla A., Nguyen K. D., Goh Y. P. S., Macrophage-mediated inflammation in metabolic disease. Nature Reviews Immunology 2011 11 11 738 749 10.1038/nri3071
91. Kim J. Y., Van De Wall E., Laplante M., Azzara A., Trujillo M. E., Hofmann S. M., Schraw T., Durand J. L., Li H., Li G., Jelicks L. A., Mehler M. F., Hui D. Y., Deshaies Y., Shulman G. I., Schwartz G. J., Scherer P. E., Obesity-associated improvements in metabolic profile through expansion of adipose tissue. Journal of Clinical Investigation 2007 117 9 2621 2637 2-s2.0-34848872799 10.1172/JCI31021 (Pubitemid 47494363)
92. Xu J., Morinaga H., Oh D., Li P., Chen A., Talukdar S., Lazarowski E., Kim J. J., GPR105 ablation prevents inflammation and improves insulin sensitivity in mice with diet-induced obesity. Journal of Immunology 2012 189 4 1992 1999 10.4049/jimmunol.1103207
93. Oh D. Y., Talukdar S., Bae E. J., Imamura T., Morinaga H., Fan W., Li P., Lu W. J., Watkins S. M., Olefsky J. M., GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010 142 5 687 698 2-s2.0-77956165390 10.1016/j.cell.2010.07.041
94. Nguyen M. T. A., Chen A., Lu W. J., Fan W., Li P., Oh D. Y., Patsouris D., Regulation of chemokine and chemokine receptor expression by PPAR γ in adipocytes and macrophages. PLoS ONE 2012 7 4 2-s2.0-84859822353 10.1371/journal.pone.0034976 e34976
95. Neels J. G., Badeanlou L., Hester K. D., Samad F., Keratinocyte-derived chemokine in obesity. Expression, regulation, and role in adipose macrophage infiltration and glucose homeostasis. Journal of Biological Chemistry 2009 284 31 20692 20698 2-s2.0-68949090345 10.1074/jbc.M109.018556
96. Han C. Y., Kargi A. Y., Omer M., Chan C. K., Wabitsch M., O'Brien K. D., Wight T. N., Chait A., Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation. Diabetes 2010 59 2 386 396 2-s2.0-77449092780 10.2337/db09-0925
97. Fu S., Watkins S. M., Hotamisligil G. S., The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling. Cell Metabolism 2012 15 5 623 634 2-s2.0-84860483727 10.1016/j.cmet.2012.03.007
98. Engin F., Hotamisligil G. S., Restoring endoplasmic reticulum function by chemical chaperones: an emerging therapeutic approach for metabolic diseases. Diabetes, Obesity and Metabolism 2010 12 2 108 115 2-s2.0-77957316569 10.1111/j.1463-1326.2010.01282.x
99. Nguyen M. T. A., Chen A., Lu W. J., Fan W., Li P., Oh D. Y., Patsouris D., Regulation of chemokine and chemokine receptor expression by PPAR γ in adipocytes and macrophages. PLoS ONE 2012 7 4 2-s2.0-84859822353 10.1371/journal.pone.0034976 e34976
100. Patsouris D., Neels J. G., Fan W. Q., Li P. P., Nguyen M. T. A., Olefsky J. M., Glucocorticoids and thiazolidinediones interfere with adipocyte-mediated macrophage chemotaxis and recruitment. Journal of Biological Chemistry 2009 284 45 31223 31235 2-s2.0-71449120759 10.1074/jbc.M109.041665
101. Stienstra R., Duval C., Keshtkar S., Van Der Laak J., Kersten S., Müller M., Peroxisome proliferator-activated receptor γ activation promotes infiltration of alternatively activated macrophages into adipose tissue. Journal of Biological Chemistry 2008 283 33 22620 22627 2-s2.0-53049093989 10.1074/jbc.M710314200
102. Pascual G., Sullivan A. L., Ogawa S., Gamliel A., Perissi V., Rosenfeld M. G., Glass C. K., Anti-inflammatory and antidiabetic roles of PPAR γ Novartis Foundation Symposium 2007 286 183 196 2-s2.0-42449160275
103. Gregoire F. M., Zhang F., Clarke H. J., Gustafson T. A., Sears D. D., Favelyukis S., Lenhard J., Rentzeperis D., Clemens L. E., Mu Y., Lavan B. E., MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema. Molecular Endocrinology 2009 23 7 975 988 2-s2.0-67649598394 10.1210/me.2008-0473
104. Ogawa S., Lozach J., Benner C., Pascual G., Tangirala R. K., Westin S., Hoffmann A., Subramaniam S., David M., Rosenfeld M. G., Glass C. K., Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 2005 122 5 707 721 2-s2.0-24144465889 10.1016/j.cell.2005.06.029 (Pubitemid 41242636)
105. Ghisletti S., Huang W., Ogawa S., Pascual G., Lin M. E., Willson T. M., Rosenfeld M. G., Glass C. K., Parallel SUMOylation-dependent pathways mediate Gene- and signal-specific transrepression by LXRs and PPAR γ Molecular Cell 2007 25 1 57 70 2-s2.0-33845970925 10.1016/j.molcel.2006.11.022 (Pubitemid 46049061)
106. Ghisletti S., Huang W., Jepsen K., Benner C., Hardiman G., Rosenfeld M. G., Glass C. K., Cooperative NCoR/SMRT interactions establish a eorepressor-based strategy for integration of inflammatory ana anti-inflammatory signaling pathways. Genes and Development 2009 23 6 681 693 2-s2.0-63049122784 10.1101/gad.1773109
107. Pascual G., Fong A. L., Ogawa S., Gamliel A., Li A. C., Perissi V., Rose D. W., Willson T. M., Rosenfeld M. G., Glass C. K., A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR- γ Nature 2005 437 7059 759 763 2-s2.0-26444471700 10.1038/nature03988 (Pubitemid 41486547)
108. Olefsky J. M., Glass C. K., Macrophages, inflammation, and insulin resistance. Annual Review of Physiology 2010 72 219 246 2-s2.0-77951918926 10.1146/annurev-physiol-021909-135846
109. Hevener A. L., Olefsky J. M., Reichart D., Nguyen M. T. A., Bandyopadyhay G., Leung H. Y., Watt M. J., Benner C., Febbraio M. A., Nguyen A. K., Folian B., Subramaniam S., Gonzalez F. J., Glass C. K., Ricote M., Macrophage PPAR γ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. Journal of Clinical Investigation 2007 117 6 1658 1669 2-s2.0-34249907880 10.1172/JCI31561 (Pubitemid 46871350)
110. Odegaard J. I., Ricardo-Gonzalez R. R., Goforth M. H., Morel C. R., Subramanian V., Mukundan L., Eagle A. R., Vats D., Brombacher F., Ferrante A. W., Chawla A., Macrophage-specific PPAR γ controls alternative activation and improves insulin resistance. Nature 2007 447 7148 1116 1120 2-s2.0-34347354309 10.1038/nature05894 (Pubitemid 47014427)
111. Lumeng C. N., Bodzin J. L., Saltiel A. R., Obesity induces a phenotypic switch in adipose tissue macrophage polarization. Journal of Clinical Investigation 2007 117 1 175 184 2-s2.0-33846026712 10.1172/JCI29881 (Pubitemid 46048464)
112. Hunter M. G., Bawden L., Brotherton D., Craig S., Cribbes S., Czaplewski L. G., Dexter T. M., Drummond A. M., Gearing A. H., Heyworth C. M., Lord B. I., McCourt M., Varley P. G., Wood L. M., Edwards R. M., Lewis P. J., BB-10010: an active variant of human macrophage inflammatory protein-1 α with improved pharmaceutical properties. Blood 1995 86 12 4400 4408 2-s2.0-0028806172
113. Odegaard J. I., Chawla A., Alternative macrophage activation and metabolism. Annual Review of Pathology 2011 6 275 297 10.1146/annurev-pathol- 011110-130138
114. Chawla A., Control of macrophage activation and function by PPARs. Circulation Research 2010 106 10 1559 1569 2-s2.0-77952997178 10.1161/CIRCRESAHA.110.216523
115. Feuerer M., Herrero L., Cipolletta D., Naaz A., Wong J., Nayer A., Lee J., Goldfine A. B., Benoist C., Shoelson S., Mathis D., Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nature Medicine 2009 15 8 930 939 2-s2.0-68349148211 10.1038/nm.2002
116. Cipolletta D., Feuerer M., Li A., Lee J., Shoelson S. E., Mathis D., PPAR- γ is a major driver of the accumulation and phenotype of adipose tissue T reg cells. Nature 2012 486 7404 549 553 10.1038/nature11132
117. Hamaguchi M., Sakaguchi S., Regulatory T cells expressing PPAR- γ control inflammation in obesity. Cell Metabolism 2012 16 1 4 6 10.1016/j.cmet.2012.06.007
118. Rakhshandehroo M., Knoch B., Müller M., Kersten S., Peroxisome proliferator-activated receptor alpha target genes. PPAR Research 2010 2010 20 2-s2.0-78349283454 10.1155/2010/612089 612089
119. Mandard S., Müller M., Kersten S., Peroxisome proliferator-activated receptor α target genes. Cellular and Molecular Life Sciences 2004 61 4 393 416 2-s2.0-1542283630 10.1007/s00018-003-3216-3 (Pubitemid 38316578)
120. Narala V. R., Adapala R. K., Suresh M. V., Brock T. G., Peters-Golden M., Reddy R. C., Leukotriene B4 is a physiologically relevant endogenous peroxisome proliferator-activated receptor- α agonist. Journal of Biological Chemistry 2010 285 29 22067 22074 2-s2.0-77954570636 10.1074/jbc.M109.085118
121. Lo Verme J., Fu J., Astarita G., La Rana G., Russo R., Calignano A., Piomelli D., The nuclear receptor peroxisome proliferator-activated receptor- α mediates the anti-inflammatory actions of palmitoylethanolamide. Molecular Pharmacology 2005 67 1 15 19 2-s2.0-11244328917 10.1124/mol.104.006353 (Pubitemid 40069962)
122. Lee S. S. T., Pineau T., Drago J., Lee E. J., Owens J. W., Kroetz D. L., Fernandez-Salguero P. M., Westphal H., Gonzalez F. J., Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Molecular and Cellular Biology 1995 15 6 3012 3022 2-s2.0-0028997684
123. Duval C., Thissen U., Keshtkar S., Accart B., Stienstra R., Boekschoten M. V., Roskams T., Kersten S., Müller M., Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57Bl/6 mice. Diabetes 2010 59 12 3181 3191 2-s2.0-78650039966 10.2337/db10-0224
124. Pini M., Rhodes D. H., Fantuzzi G., Hematological and acute-phase responses to diet-induced obesity in IL-6 KO mice. Cytokine 2011 56 3 708 716 2-s2.0-81455154345 10.1016/j.cyto.2011.09.015
125. Lalloyer F., Wouters K., Baron M., Caron S., Vallez E., Vanhoutte J., Baugé E., Shiri-Sverdlov R., Hofker M., Staels B., Tailleux A., Peroxisome proliferator-activated receptor- α gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 7 1573 1579 2-s2.0-79959696573 10.1161/ATVBAHA.110.220525
126. Shiri-Sverdlov R., Wouters K., Gorp P. J. V., Gijbels M. J., Noel B., Buffat L., Staels B., Maeda N., Bilsen M. V., Hofker M. H., Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates. Journal of Hepatology 2006 44 4 732 741 2-s2.0-33644919989 10.1016/j.jhep.2005.10.033
127. Stienstra R., Saudale F., Duval C., Keshtkar S., Groener J. E. M., Van Rooijen N., Staels B., Kersten S., Müller M., Kupffer cells promote hepatic steatosis via interleukin-1 β -dependent suppression of peroxisome proliferator-activated receptor α activity. Hepatology 2010 51 2 511 522 2-s2.0-75449101395 10.1002/hep.23337
128. Delerive P., Gervois P., Fruchart J. C., Staels B., Induction of I B α expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor- α activators. Journal of Biological Chemistry 2000 275 47 36703 36707 2-s2.0-0034711185 10.1074/jbc.M004045200 (Pubitemid 32002075)
129. Gervois P., Vu-Dac N., Kleemann R., Kockx M., Dubois G., Laine B., Kosykh V., Fruchart J. C., Kooistra T., Staels B., Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta. Journal of Biological Chemistry 2001 276 36 33471 33477 2-s2.0-0035823551 10.1074/jbc.M102839200
130. Bougarne N., Paumelle R., Caron S., Hennuyer N., Mansouri R., Gervois P., Staels B., Haegeman G., De Bosscher K., PPAR α blocks glucocorticoid receptor α -mediated transactivation but cooperates with the activated glucocorticoid receptor α for transrepression on NF- B. Proceedings of the National Academy of Sciences of the United States of America 2009 106 18 7397 7402 2-s2.0-66149149061 10.1073/pnas.0806742106
131. Stienstra R., Mandard S., Tan N. S., Wahli W., Trautwein C., Richardson T. A., Lichtenauer-Kaligis E., Kersten S., Müller M., The Interleukin-1 receptor antagonist is a direct target gene of PPAR α in liver. Journal of Hepatology 2007 46 5 869 877 2-s2.0-34047187449 10.1016/j.jhep.2006.11.019 (Pubitemid 46529035)
132. François M., Richette P., Tsagris L., Fitting C., Lemay C., Benallaoua M., Tahiri K., Corvol M. T., Activation of the peroxisome proliferator-activated receptor α pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes. Arthritis and Rheumatism 2006 54 4 1233 1245 2-s2.0-33646348965 10.1002/art.21728 (Pubitemid 43672935)
133. Moffit J. S., Koza-Taylor P. H., Holland R. D., Thibodeau M. S., Beger R. D., Lawton M. P., Manautou J. E., Differential gene expression in mouse liver associated with the hepatoprotective effect of clofibrate. Toxicology and Applied Pharmacology 2007 222 2 169 179 2-s2.0-34447632203 10.1016/j.taap.2007. 04.008 (Pubitemid 47094866)
134. Rogue A., Lambert C., Jossé R., Antherieu S., Spire C., Guillouzo A., Comparative gene expression profiles induced by PPAR γ and PPAR α / γ agonists in human hepatocytes. PLoS ONE 2011 6 4 e18816 10.1371/journal.pone.0018816
135. Wong J. S., Gill S. S., Gene expression changes induced in mouse liver by di(2-ethylhexyl) phthalate. Toxicology and Applied Pharmacology 2002 185 3 180 196 2-s2.0-0036935523 10.1006/taap.2002.9540 (Pubitemid 36062792)
136. Rakhshandehroo M., Stienstra R., de Wit N. J., Bragt M. C. E., Haluzik M., Mensink R. P., Müller M., Kersten S., Plasma mannose-binding lectin is stimulated by PPAR α in humans. American Journal of Physiology 2012 302 5 E595 E602 2-s2.0-84857253804 10.1152/ajpendo.00299.2011
137. Pang M., de la Monte S. M., Longato L., Tong M., He J., Chaudhry R., Duan K., Ouh J., Wands J. R., PPAR δ agonist attenuates alcohol-induced hepatic insulin resistance and improves liver injury and repair. Journal of Hepatology 2009 50 6 1192 1201 2-s2.0-67349255861 10.1016/j.jhep.2009.01.021
138. Hellemans K., Michalik L., Dittie A., Knorr A., Rombouts K., De Jong J., Heirman C., Quartier E., Schuit F., Wahli W., Geerts A., Peroxisome proliferator-activated receptor- β signaling contributes to enhanced proliferation of hepatic stellate cells. Gastroenterology 2003 124 1 184 201 2-s2.0-0037221210 10.1053/gast.2003.50015 (Pubitemid 36055351)
139. Sanderson L. M., Boekschoten M. V., Desvergne B., Müller M., Kersten S., Transcriptional profiling reveals divergent roles of PPAR α and PPAR β / δ in regulation of gene expression in mouse liver. Physiological Genomics 2010 41 1 42 52 2-s2.0-77949676576 10.1152/physiolgenomics.00127.2009
140. Shan W., Nicol C. J., Ito S., Bility M. T., Kennett M. J., Ward J. M., Gonzalez F. J., Peters J. M., Peroxisome proliferator-activated receptor- β / δ protects against chemically induced liver toxicity in mice. Hepatology 2008 47 1 225 235 2-s2.0-38649104434 10.1002/hep.21925 (Pubitemid 351171060)
141. Liu S., Hatano B., Zhao M., Yen C. C., Kang K., Reilly S. M., Gangl M. R., Gorgun C., Balschi J. A., Ntambi J. M., Lee C. H., Role of peroxisome proliferator-activated receptor δ / β in hepatic metabolic regulation. Journal of Biological Chemistry 2011 286 2 1237 1247 2-s2.0-78651384181 10.1074/jbc.M110.138115
142. Lee M. Y., Choi R., Kim H. M., Cho E. J., Kim B. H., Choi Y. S., Lee E. Y., Yang Y. C., Shin J. Y., Shin Y. G., Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism. Experimental and Molecular Medicine 2012 44 10 578 585 10.3858/emm.2012.44.10.066
143. Sanchez-Siles A. A., Ishimura N., Rumi M. A. K., Tamagawa Y., Ito S., Ishihara S., Nabika T., Kinoshita Y., Administration of PPAR β / δ agonist reduces copper-induced liver damage in mice: possible implications in clinical practice. Journal of Clinical Biochemistry and Nutrition 2011 49 1 42 49 2-s2.0-79959960189 10.3164/jcbn.10-139
144. Iwaisako K., Haimerl M., Paik Y.-H., Taura K., Kodama Y., Sirlin C., Yu E., Yu R. T., Downes M., Evans R. M., Brenner D. A., Schnabl B., Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist. Proceedings of the National Academy of Sciences of the United States of America 2012 109 21 E1369 E1376 10.1073/pnas.1202464109
145. Gross B., Hennuyer N., Bouchaert E., Rommens C., Grillot D., Mezdour H., Staels B., Generation and characterization of a humanized PPAR δ mouse model. British Journal of Pharmacology 2011 164 1 192 208 10.1111/j.1476-5381. 2011.01359.x
146. Morán-Salvador E., López-Parra M., García-Alonso V., Titos E., Martínez-Clemente M., González-Périz A., López-Vicario C., Barak Y., Arroyo V., Clària J., Role for PPAR γ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts. FASEB Journal 2011 25 8 2538 2550 2-s2.0-80051706346 10.1096/fj.10-173716
147. Gazit V., Huang J., Weymann A., Rudnick D. A., Analysis of the role of hepatic PPAR γ expression during mouse liver regeneration. Hepatology 2012 56 4 1489 1498 10.1002/hep.25880
148. Chen Z., Vigueira P. A., Qi N., McDonald W. G., Colca J. R., Kletzien R. F., Finck B. N., Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor γ -sparing thiazolidinedione. Journal of Biological Chemistry 2012 287 28 23537 23548 10.1074/jbc.M112.363960
149. 2 reduces recruitment of bone marrow-derived monocyte/macrophages in chronic liver injury in mice. Hepatology 2012 56 1 350 360 10.1002/hep.25672
150. Lu B., Moser A. H., Shigenaga J. K., Feingold K. R., Grunfeld C., Type II nuclear hormone receptors, coactivator, and target gene repression in adipose tissue in the acute-phase response. Journal of Lipid Research 2006 47 10 2179 2190 2-s2.0-33845586654 10.1194/jlr.M500540-JLR200 (Pubitemid 44936128)
151. Beigneux A. P., Moser A. H., Shigenaga J. K., Grunfeld C., Feingold K. R., The acute phase response is associated with retinoid X receptor repression in rodent liver. Journal of Biological Chemistry 2000 275 21 16390 16399 2-s2.0-0034717067 10.1074/jbc.M000953200 (Pubitemid 30366957)
152. Hill M. R., Young M. D., Mccurdy C. M., Gimble J. M., Decreased expression of murine PPAR γ in adipose tissue during endotoxemia. Endocrinology 1997 138 7 3073 3076 2-s2.0-0030957958 10.1210/en.138.7.3073 (Pubitemid 27258545)
153. Kim M. S., Shigenaga J., Moser A., Feingold K., Grunfeld C., Repression of farnesoid X receptor during the acute phase response. Journal of Biological Chemistry 2003 278 11 8988 8995 2-s2.0-0037646504 10.1074/jbc.M212633200 (Pubitemid 36800376)
154. Feingold K., Kim M. S., Shigenaga J., Moser A., Grunfeld C., Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response. American Journal of Physiology 2004 286 2 E201 E207 2-s2.0-0942287345 (Pubitemid 38140310)
155. Kim M. S., Sweeney T. R., Shigenaga J. K., Chui L. G., Moser A., Grunfeld C., Feingold K. R., Tumor necrosis factor and interleukin 1 decrease RXR α PPAR α PPAR γ LXR α and the coactivators SRC-1, PGC-1 α and PGC-1 β in liver cells. Metabolism 2007 56 2 267 279 2-s2.0-33846174641 10.1016/j.metabol.2006.10.007 (Pubitemid 46084934)
156. Haskova Z., Hoang B., Luo G., Morgan L. A., Billin A. N., Barone F. C., Shearer B. G., Barton M. E., Kilgore K. S., Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPAR β / δ ligand GW0742. Inflammation Research 2008 57 7 314 321 2-s2.0-51849149335 10.1007/s00011-007-7157-4
157. Hill M. R., Clarke S., Rodgers K., Thornhill B., Peters J. M., Gonzalez F. J., Gimble J. M., Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia. Infection and Immunity 1999 67 7 3488 3493 2-s2.0-0033007231 (Pubitemid 29291520)
158. Feingold K. R., Wang Y., Moser A., Shigenaga J. K., Grunfeld C., LPS decreases fatty acid oxidation and nuclear hormone receptors in the kidney. Journal of Lipid Research 2008 49 10 2179 2187 2-s2.0-67649814105 10.1194/jlr.M800233-JLR200
159. Barclay T. B., Peters J. M., Sewer M. B., Ferrari L., Gonzalez F. J., Morgan E. T., Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor- α dependent. Journal of Pharmacology and Experimental Therapeutics 1999 290 3 1250 1257 2-s2.0-0032806042 (Pubitemid 29400267)
160. Stienstra R., Saudale F., Duval C., Keshtkar S., Groener J. E. M., Van Rooijen N., Staels B., Kersten S., Müller M., Kupffer cells promote hepatic steatosis via interleukin-1 β -dependent suppression of peroxisome proliferator-activated receptor α activity. Hepatology 2010 51 2 511 522 2-s2.0-75449101395 10.1002/hep.23337
161. Mulvey C. K., Ferguson J. F., Tabita-Martinez J., Peroxisome proliferator-activated receptor-alpha agonism with fenofibrate does not suppress inflammatory responses to evoked endotoxemia. Journal of the American Heart Association 2012 1 4 e002923
162. Palmer C. N. A., Hsu M. H., Griffin K. J., Raucy J. L., Johnson E. F., Peroxisome proliferator activated receptor- α expression in human liver. Molecular Pharmacology 1998 53 1 14 22 2-s2.0-0031952238 (Pubitemid 28068368)
163. Gervois P., Kleemann R., Pilon A., Percevault F., Koenig W., Staels B., Kooistra T., Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate. Journal of Biological Chemistry 2004 279 16 16154 16160 2-s2.0-1942533537 10.1074/jbc.M400346200 (Pubitemid 38509307)
164. Jonkers I. J., Mohrschladt M. F., Westendorp R. G., Van der Laarse A., Smelt A. H., Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial. American Journal of Medicine 2002 112 4 275 280 2-s2.0-0036121471 10.1016/S0002-9343(01)01123-8 (Pubitemid 34219440)
165. Jozefowicz E., Brisson H., Rozenberg S., Mebazaa A., Gelé P., Callebert J., Lebuffe G., Vallet B., Bordet R., Tavernier B., Activation of peroxisome proliferator-activated receptor- α by fenofibrate prevents myocardial dysfunction during endotoxemia in rats. Critical Care Medicine 2007 35 3 856 863 2-s2.0-33947133355 10.1097/01.CCM.0000256843.75446.A0 (Pubitemid 46407802)
166. Mansouri R. M., Baugé E., Staels B., Gervois P., Systemic and distal repercussions of liver-specific peroxisome proliferator-activated receptor- α control of the acute-phase response. Endocrinology 2008 149 6 3215 3223 2-s2.0-44249124486 10.1210/en.2007-1339 (Pubitemid 351724503)
167. Kapoor A., Shintani Y., Collino M., Osuchowski M. F., Busch D., Patel N. S. A., Sepodes B., Castiglia S., Fantozzi R., Bishop-Bailey D., Mota-Filipe H., Yaqoob M. M., Suzuki K., Bahrami S., Desvergne B., Mitchell J. A., Thiemermann C., Protective role of peroxisome proliferator-activated receptor- β / δ in septic shock. American Journal of Respiratory and Critical Care Medicine 2010 182 12 1506 1515 2-s2.0-78650212702 10.1164/rccm.201002-0240OC
168. Liu D., Zeng B. X., Zhang S. H., Wang Y. L., Zeng L., Geng Z. L., Zhang S. F., Rosiglitazone, a peroxisome proliferator-activated receptor- γ agonist, reduces acute lung injury in endotoxemic rats. Critical Care Medicine 2005 33 10 2309 2316 2-s2.0-26444600114 10.1097/01.CCM.0000183161.81503.7D (Pubitemid 41437486)
169. Liu D., Zeng B. X., Zhang S. H., Yao S. L., Rosiglitazone, an agonist of peroxisome proliferator-activated receptor γ reduces pulmonary inflammatory response in a rat model of endotoxemia. Inflammation Research 2005 54 11 464 470 2-s2.0-28044431614 10.1007/s00011-005-1379-0 (Pubitemid 41690375)
170. Collin M., Patel N. S. A., Dugo L., Thiemermann C., Role of peroxisome proliferator-activated receptor- γ in the protection afforded by 15-deoxyΔ12,14 prostaglandin J 2 against the multiple organ failure caused by endotoxin. Critical Care Medicine 2004 32 3 826 831 2-s2.0-1542719543 10.1097/01.CCM.0000114821.25573.E7 (Pubitemid 38340084)
171. Hwang J. S., Kang E. S., Ham S. A., Yoo T., Lee H., Paek K. S., Park C., Kim J.-H., Lim D.-S., Seo H. G., Activation of peroxisome proliferator-activated receptor γ by rosiglitazone inhibits lipopolysaccharide-induced release of high mobility group box 1. Mediators of Inflammation 2012 2012 9 352807 10.1155/2012/352807
172. Thieringer R., Fenyk-Melody J. E., Le Grand C. B., Shelton B. A., Detmers P. A., Somers E. P., Carbin L., Moller D. E., Wright S. D., Berger J., Activation of peroxisome proliferator-activated receptor γ does not inhibit IL-6 or TNF- α responses of macrophages to lipopolysaccharide in vitro or in vivo. Journal of Immunology 2000 164 2 1046 1054 2-s2.0-0034650330 (Pubitemid 30043733)
173. Fan W., Liu Y., Wu Z., Hong Y., Zhu H., Hou Y., Yin Y., Han J., Effects of rosiglitazone, an agonist of the peroxisome proliferator-activated receptor γ on intestinal damage induced by Escherichia coli lipopolysaccharide in weaned pigs. American Journal of Veterinary Research 2010 71 11 1331 1338 2-s2.0-78149401439 10.2460/ajvr.71.11.1331
174. Liu Y., Shi J., Lu J., Meng G., Zhu H., Hou Y., Yin Y., Zhao S., Ding B., Activation of peroxisome proliferator-activated receptor- γ potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge. Innate Immunity 2009 15 3 169 178 2-s2.0-66149165911 10.1177/1753425908102014
175. Bünger M., Van Den Bosch H. M., Van Der Meijde J., Kersten S., Hooiveld G. J. E. J., Müller M., Genome-wide analysis of PPAR α activation in murine small intestine. Physiological Genomics 2007 30 2 192 204 2-s2.0-34547435660 10.1152/physiolgenomics.00198.2006 (Pubitemid 47173282)
176. Mansén A., Guardiola-Diaz H., Rafter J., Branting C., Gustafsson J. Å., Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa. Biochemical and Biophysical Research Communications 1996 222 3 844 851 2-s2.0-0029949369 10.1006/bbrc.1996.0832 (Pubitemid 26194840)
177. Azuma Y. T., Nishiyama K., Matsuo Y., Kuwamura M., Morioka A., Nakajima H., Takeuchi T., PPAR α contributes to colonic protection in mice with DSS-induced colitis. International Immunopharmacology 2010 10 10 1261 1267 2-s2.0-77957237836 10.1016/j.intimp.2010.07.007
178. Riccardi L., Mazzon E., Bruscoli S., Esposito E., Crisafulli C., Paola R. D., Caminiti R., Riccardi C., Cuzzocrea S., Peroxisome proliferator-activated receptor- α modulates the anti-inflammatory effect of glucocorticoids in a model of inflammatory bowel disease in mice. Shock 2009 31 3 308 316 2-s2.0-62449207118 10.1097/SHK.0b013e31818339e7
179. Cuzzocrea S., Di Paola R., Mazzon E., Genovese T., Muià C., Centorrino T., Caputi A. P., Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR- α) in the development of inflammatory bowel disease in mice. Laboratory Investigation 2004 84 12 1643 1654 2-s2.0-10044243883 10.1038/labinvest.3700185 (Pubitemid 39600571)
180. Hollingshead H. E., Morimura K., Adachi M., Kennett M. J., Billin A. N., Willson T. M., Gonzalez F. J., Peters J. M., PPAR β / δ protects against experimental colitis through a ligand-independent mechanism. Digestive Diseases and Sciences 2007 52 11 2912 2919 2-s2.0-34848838350 10.1007/s10620-006-9644-9 (Pubitemid 47512523)
181. Su W., Bush C. R., Necela B. M., Calcagno S. R., Murray N. R., Fields A. P., Thompson E. A., Differential expression, distribution, and function of PPAR- γ in the proximal and distal colon. Physiological Genomics 2007 30 3 342 353 2-s2.0-34548069753 10.1152/physiolgenomics.00042.2007 (Pubitemid 47296193)
182. Lefebvre A. M., Chen I., Desreumaux P., Najib J., Fruchart J. C., Geboes K., Briggs M., Heyman R., Auwerx J., Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APC(Min)/+ mice. Nature Medicine 1998 4 9 1053 1057 2-s2.0-0031694577 10.1038/2036 (Pubitemid 28417338)
183. Saez E., Tontonoz P., Nelson M. C., Alvarez J. G. A., Ming U T., Baird S. M., Thomazy V. A., Evans R. M., Activators of the nuclear receptor PPAR γ enhance colon polyp formation. Nature Medicine 1998 4 9 1058 1061 2-s2.0-0031667938 10.1038/2042 (Pubitemid 28417339)
184. Girnun G. D., Smith W. M., Drori S., Sarraf P., Mueller E., Eng C., Nambiar P., Rosenberg D. W., Bronson R. T., Edelmann W., Kucherlapati R., Gonzalez F. J., Spiegelman B. M., APC-dependent suppression of colon carcinogenesis by PPAR γ Proceedings of the National Academy of Sciences of the United States of America 2002 99 21 13771 13776 2-s2.0-0037109043 10.1073/pnas.162480299 (Pubitemid 35215456)
185. Dubuquoy L., Å Jansson E., Deeb S., Rakotobe S., Karoui M., Colombel J. F., Auwerx J., Pettersson S., Desreumaux P., Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis. Gastroenterology 2003 124 5 1265 1276 2-s2.0-0037847511 10.1016/S0016-5085(03) 00271-3 (Pubitemid 36531802)
186. Evans N. P., Misyak S. A., Schmelz E. M., Guri A. J., Hontecillas R., Bassaganya-Riera J., Conjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPAR γ Journal of Nutrition 2010 140 3 515 521 2-s2.0-77249105986 10.3945/jn.109.115642
187. Adachi M., Kurotani R., Morimura K., Shah Y., Sanford M., Madison B. B., Gumucio D. L., Marin H. E., Peters J. M., Young H. A., Gonzalez F. J., Peroxisome proliferator activated receptor γ in colonic epithelial cells protects against experimental inflammatory bowel disease. Gut 2006 55 8 1104 1113 2-s2.0-33746159991 10.1136/gut.2005.081745 (Pubitemid 44085676)
188. Kelly D., Campbell J. I., King T. P., Grant G., Jansson E. A., Coutts A. G. P., Pettersson S., Conway S., Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shutting of PPAR- γ and ReIA. Nature Immunology 2004 5 1 104 112 2-s2.0-0347756655 10.1038/ni1018 (Pubitemid 38081475)
189. Mwinyi J., Grete-Wenger C., Eloranta J. J., Kullak-Ublick G. A., The impact of PPAR γ genetic variants on IBD susceptibility and IBD disease course. PPAR Research 2012 2012 13 2-s2.0-84858330062 10.1155/2012/349469 349469
190. Guri A. J., Mohapatra S. K., Horne W. T., Hontecillas R., Bassaganya-Riera J., The Role of T cell PPAR γ in mice with experimental inflammatory bowel disease. BMC Gastroenterology 2010 10, article 60 2-s2.0-77953248869 10.1186/1471-230X-10-60
191. Hontecillas R., Horne W. T., Climent M., Guri A. J., Evans C., Zhang Y., Sobral B. W., Bassaganya-Riera J., Immunoregulatory mechanisms of macrophage PPAR- γ in mice with experimental inflammatory bowel disease. Mucosal Immunology 2011 4 3 304 313 2-s2.0-79955110851 10.1038/mi.2010.75
192. Hontecillas R., Bassaganya-Riera J., Peroxisome proliferator-activated receptor γ is required for regulatory CD4+ T cell-mediated protection against colitis. Journal of Immunology 2007 178 5 2940 2949 2-s2.0-33847403883 (Pubitemid 46333173)
193. Moreno S., Farioli-vecchioli S., Cerù M. P., Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 2004 123 1 131 145 2-s2.0-0345118108 10.1016/j.neuroscience.2003.08.064 (Pubitemid 37518482)
194. Braissant O., Wahli W., Differential expression of peroxisome proliferator-activated receptor- α-β and-γ during rat embryonic development. Endocrinology 1998 139 6 2748 2754 2-s2.0-0031788318 10.1210/en.139.6.2748 (Pubitemid 28512383)
195. Krémarik-Bouillaud P., Schohn H., Dauça M., Regional distribution of PPAR β in the cerebellum of the rat. Journal of Chemical Neuroanatomy 2000 19 4 225 232 2-s2.0-0033623139 10.1016/S0891-0618(00)00065-X
196. Benani A., Krémarik-Bouillaud P., Bianchi A., Netter P., Minn A., Dauça M., Evidence for the presence of both peroxisome proliferator-activated receptors alpha and beta in the rat spinal cord. Journal of Chemical Neuroanatomy 2003 25 1 29 38 2-s2.0-0037255574 10.1016/S0891- 0618(02)00093-5 (Pubitemid 36164853)
197. Benani A., Heurtaux T., Netter P., Minn A., Activation of peroxisome proliferator-activated receptor alpha in rat spinal cord after peripheral noxious stimulation. Neuroscience Letters 2004 369 1 59 63 2-s2.0-5644266308 10.1016/j.neulet.2004.07.056 (Pubitemid 39369503)
198. D'Agostino G., La Rana G., Russo R., Sasso O., Iacono A., Esposito E., Raso G. M., Cuzzocrea S., Lo Verme J., Piomelli D., Meli R., Calignano A., Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor- α agonist, modulates carrageenan-induced paw edema in mice. Journal of Pharmacology and Experimental Therapeutics 2007 322 3 1137 1143 2-s2.0-34548068297 10.1124/jpet.107.123265 (Pubitemid 47295805)
199. Defaux A., Zurich M. G., Braissant O., Honegger P., Monnet-Tschudi F., Effects of the PPAR- β agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination. Journal of Neuroinflammation 2009 6, article 15 2-s2.0-66449124004 10.1186/1742-2094-6-15
200. Polak P. E., Kalinin S., Dello Russo C., Gavrilyuk V., Sharp A., Peters J. M., Richardson J., Willson T. M., Weinberg G., Feinstein D. L., Protective effects of a peroxisome proliferator-activated receptor- β / δ agonist in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 2005 168 1-2 65 75 2-s2.0-25844473319 10.1016/j.jneuroim.2005.07.006 (Pubitemid 41396404)
201. Jana M., Pahan K., Gemfibrozil, a lipid lowering drug, inhibits the activation of primary human microglia via peroxisome proliferator-activated receptor β Neurochemical Research 2012 37 5 1718 1729 2-s2.0-84859629618 10.1007/s11064-012-0781-6
202. Kocalis H. E., Turney M. K., Printz R. L., Laryea G. N., Muglia L. J., Davies S. S., McGuinness O. P., Niswender K. D., Neuron-specific deletion of peroxisome proliferator-activated receptor delta (PPAR δ) in mice leads to increased susceptibility to diet-induced obesity. PLoS ONE 2012 7 8 e42981 10.1371/journal.pone.0042981
203. Breidert T., Callebert J., Heneka M. T., Landreth G., Launay J. M., Hirsch E. C., Protective action of the peroxisome proliferator-activated receptor- γ agonist pioglitazone in a mouse model of Parkinson's disease. Journal of Neurochemistry 2002 82 3 615 624 2-s2.0-0036326074 10.1046/j.1471-4159.2002.00990.x (Pubitemid 34831499)
204. Dehmer T., Heneka M. T., Sastre M., Dichgans J., Schulz J. B., Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I B α induction and block of NF B and iNOS activation. Journal of Neurochemistry 2004 88 2 494 501 2-s2.0-0347087323 (Pubitemid 38084565)
205. Lockyer P., Schisler J. C., Patterson C., Willis M. S., Minireview: won't get fooled again: the nonmetabolic roles of peroxisome proliferator-activated receptors (PPARs) in the heart. Molecular Endocrinology 2010 24 6 1111 1119 2-s2.0-77954821171 10.1210/me.2009-0374
206. Ogata T., Miyauchi T., Sakai S., Takanashi M., Irukayama-Tomobe Y., Yamaguchi I., Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway. Journal of the American College of Cardiology 2004 43 8 1481 1488 2-s2.0-1942484870 10.1016/j.jacc.2003.11.043 (Pubitemid 38496358)
207. Georgiadi A., Boekschoten M. V., Müller M., Kersten S., Detailed transcriptomics analysis of the effect of dietary fatty acids on gene expression in the heart. Physiological Genomics 2012 44 6 352 361 2-s2.0-84859477031 10.1152/physiolgenomics.00115.2011
208. Smeets P. J. H., De Vogel-van Den Bosch H. M., Willemsen P. H. M., Stassen A. P., Ayoubi T., Van Der Vusse G. J., Van Bilsen M., Transcriptomic analysis of PPAR α -dependent alterations during cardiac hypertrophy. Physiological Genomics 2008 36 1 15 23 2-s2.0-57749105321 10.1152/ physiolgenomics.90296.2008
209. Smeets P. J. H., Teunissen B. E. J., Planavila A., De Vogel-Van Den Bosch H., Willemsen P. H. M., Van Der Vusse G. J., Van Bilsen M., Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxisome proliferator-activated receptors PPAR α and PPAR δ Journal of Biological Chemistry 2008 283 43 29109 29118 2-s2.0-57649155050 10.1074/jbc.M802143200
210. Ding G., Cheng L., Qin Q., Frontin S., Yang Q., PPAR δ modulates lipopolysaccharide-induced TNF α inflammation signaling in cultured cardiomyocytes. Journal of Molecular and Cellular Cardiology 2006 40 6 821 828 2-s2.0-33744519163 10.1016/j.yjmcc.2006.03.422 (Pubitemid 43817042)
211. Álvarez-Guardia D., Palomer X., Coll T., Serrano L., Davidson M. M., Merlos M., El Kochairi I., Michalik L., Wahli W., Vázquez-Carrera M., PPAR β / δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells. Biochimica et Biophysica Acta 2011 1811 2 59 67 10.1016/j.bbalip.2010.11.002
212. Penas F., Mirkin G. A., Hovsepian E., PPAR γ ligand treatment inhibits cardiac inflammatory mediators induced by infection with different lethality strains of Trypanosoma cruzi. Biochimica et Biophysica Acta 2013 1832 1 239 248 10.1016/j.bbadis.2012.08.007
213. Hovsepian E., Mirkin G. A., Penas F., Manzano A., Bartrons R., Goren N. B., Modulation of inflammatory response and parasitism by 15-Deoxy-Δ12,14 prostaglandin J2 in Trypanosoma cruzi -infected cardiomyocytes. International Journal for Parasitology 2011 41 5 553 562 2-s2.0-79952693649 10.1016/j.ijpara.2010.12.002
214. Reiterer G., Toborek M., Hennig B., Peroxisome proliferator activated receptors α and γ require zinc for their anti-inflammatory properties in porcine vascular endothelial cells. Journal of Nutrition 2004 134 7 1711 1715 2-s2.0-3042700222 (Pubitemid 38886559)
215. Wang N., Verna L., Chen N. G., Chen J., Li H., Forman B. M., Stemerman M. B., Constitutive activation of peroxisome proliferator-activated receptor- γ suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells. Journal of Biological Chemistry 2002 277 37 34176 34181 2-s2.0-0037072826 10.1074/jbc.M203436200
216. Rival Y., Benéteau N., Taillandier T., Pezet M., Dupont-Passelaigue E., Patoiseau J. F., Junquéro D., Colpaert F. C., Delhon A., PPAR α and PPAR δ activators inhibit cytokine-induced nuclear translocation of NF- B and expression of VCAM-1 in EAhy926 endothelial cells. European Journal of Pharmacology 2002 435 2-3 143 151 2-s2.0-0037168869 10.1016/S0014-2999(01)01589-8 (Pubitemid 34131694)
217. Berger J., Leibowitz M. D., Doebber T. W., Elbrecht A., Zhang B., Zhou G., Biswas C., Cullinan C. A., Hayes N. S., Li Y., Tanen M., Ventre J., Wu M. S., Berger G. D., Mosley R., Marquis R., Santini C., Sahoo S. P., Tolman R. L., Smith R. G., Moller D. E., Novel peroxisome proliferator-activated receptor (PPAR) γ and PPAR δ ligands produce distinct biological effects. Journal of Biological Chemistry 1999 274 10 6718 6725 2-s2.0-0033525535 10.1074/jbc.274.10.6718 (Pubitemid 29111093)
218. Liang Y. J., Liu Y. C., Chen C. Y., Lai L. P., Shyu K. G., Juang S. J., Wang B. W., Leu J. G., Comparison of PPAR δ and PPAR γ in inhibiting the pro-inflammatory effects of C-reactive protein in endothelial cells. International Journal of Cardiology 2010 143 3 361 367 2-s2.0-77956616203 10.1016/j.ijcard.2009.03.100
219. Fan Y., Wang Y., Tang Z., Zhang H., Qin X., Zhu Y., Guan Y., Wang X., Staels B., Chien S., Wang N., Suppression of pro-inflammatory adhesion molecules by PPAR- δ in human vascular endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 2 315 321 2-s2.0-38549127422 10.1161/ATVBAHA.107.149815 (Pubitemid 351161205)
220. Lee C. H., Chawla A., Urbiztondo N., Liao D., Boisvert W. A., Evans R. M., Transcriptional repression of atherogenic inflammation: modulation by PPAR δ Science 2003 302 5644 453 457 2-s2.0-0142116239 10.1126/science.1087344 (Pubitemid 37296272)
221. Maeng Y. S., Min J. K., Kim J. H., Yamagishi A., Mochizuki N., Kwon J. Y., Park Y. W., Kim Y. M., Kwon Y. G., ERK is an anti-inflammatory signal that suppresses expression of NF- B-dependent inflammatory genes by inhibiting IKK activity in endothelial cells. Cellular Signalling 2006 18 7 994 1005 2-s2.0-33645108170 10.1016/j.cellsig.2005.08.007
222. Woo C. H., Massett M. P., Shishido T., Itoh S., Ding B., McClain C., Che W., Vulapalli S. R., Yan C., Abe J. I., ERK5 activation inhibits inflammatory responses via peroxisome proliferator-activated receptor δ (PPAR δ) stimulation. Journal of Biological Chemistry 2006 281 43 32164 32174 2-s2.0-33845956237 10.1074/jbc.M602369200 (Pubitemid 46036771)
223. Delerive P., Martin-Nizard F., Chinetti G., Trottein F., Fruchart J. C., Najib J., Duriez P., Staels B., Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circulation Research 1999 85 5 394 402 2-s2.0-0033520304 (Pubitemid 29409616)
224. Marx N., Bourcier T., Sukhova G. K., Libby P., Plutzky J., PPAR γ activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPAR γ as a potential mediator in vascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 3 546 551 2-s2.0-0032587328 (Pubitemid 29135154)
225. Marx N., Mach F., Sauty A., Leung J. H., Sarafi M. N., Ransohoff R. M., Libby P., Plutzky J., Luster A. D., Peroxisome proliferator-activated receptor- γ activators inhibit IFN- γ -induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. Journal of Immunology 2000 164 12 6503 6508 2-s2.0-0034660182 (Pubitemid 30408835)
226. Pasceri V., Wu H. D., Willerson J. T., Yeh E. T. H., Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor- γ activators. Circulation 2000 101 3 235 238 2-s2.0-0034711678 (Pubitemid 30054148)
227. Qu A., Shah Y. M., Manna S. K., Gonzalez F. J., Disruption of endothelial peroxisome proliferator-activated receptor γ accelerates diet-induced atherogenesis in LDL receptor-null mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 1 65 73 2-s2.0-83655167182 10.1161/ATVBAHA.111.239137
228. Reddy A. T., Lakshmi S. P., Kleinhenz J. M., Sutliff R. L., Hart C. M., Reddy R. C., Endothelial cell peroxisome proliferator-activated receptor γ reduces endotoxemic pulmonary inflammation and injury. Journal of Immunology 2012 189 11 5411 5420 10.4049/jimmunol.1201487
229. Desvergne B., Wahli W., Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrine Reviews 1999 20 5 649 688 2-s2.0-0033305213 (Pubitemid 30650602)
230. Harmon R. J., Physiology of mastitis and factors affecting somatic cell counts. Journal of Dairy Science 1994 77 7 2103 2112 2-s2.0-0028472830
231. Uthaisangsook S., Day N. K., Bahna S. L., Good R. A., Haraguchi S., Innate immunity and its role against infections. Annals of Allergy, Asthma and Immunology 2002 88 3 253 264 2-s2.0-0036130295 (Pubitemid 34245968)
232. Buitenhuis B., Røntved C. M., Edwards S. M., Ingvartsen K. L., Sørensen P., In depth analysis of genes and pathways of the mammary gland involved in the pathogenesis of bovine Escherichia coli-mastitis. BMC Genomics 2011 12, article 130 2-s2.0-79952049778 10.1186/1471-2164-12-130
233. Schweiker R. S., ACLI presidential address. American Council of Life Insurance. Transactions of the Association of Life Insurance Medical Directors of America 1991 74 14 22 2-s2.0-0026038849
234. Yang D., Yang H., Li W., Zhao B., Ouyang Z., Liu Z., Zhao Y., Fan N., Song J., Tian J., Li F., Zhang J., Chang L., Pei D., Chen Y. E., Lai L., Generation of PPAR γ mono-allelic knockout pigs via zinc-finger nucleases and nuclear transfer cloning. Cell Research 2011 21 6 979 982 2-s2.0-79960050589 10.1038/cr.2011.70
235. Moyes K. M., Drackley J. K., Morin D. E., Bionaz M., Rodriguez-Zas S. L., Everts R. E., Lewin H. A., Loor J. J., Gene network and pathway analysis of bovine mammary tissue challenged with Streptococcus uberis reveals induction of cell proliferation and inhibition of PPAR signaling as potential mechanism for the negative relationships between immune response and lipid metabolism. BMC Genomics 2009 10, article 542 2-s2.0-71549117271 10.1186/1471-2164-10-542
236. Gervois P., Mansouri R. M., PPAR α as a therapeutic target in inflammation-associated diseases. Expert Opinion on Therapeutic Targets 2012 16 11 1113 1125 10.1517/14728222.2012.715633
237. Schlegel G., Keller J., Hirche F., Geiszler S., Schwarz F. J., Ringseis R., Stangl G. I., Eder K., Expression of genes involved in hepatic carnitine synthesis and uptake in dairy cows in the transition period and at different stages of lactation. BMC Veterinary Research 2012 8, article 28 2-s2.0-84858059373 10.1186/1746-6148-8-28
238. Ribet C., Montastier E., Valle C., Bezaire V., Mazzucotelli A., Mairal A., Viguerie N., Langin D., Peroxisome proliferator-activated receptor- α control of lipid and glucose metabolism in human white adipocytes. Endocrinology 2010 151 1 123 133 2-s2.0-73649141006 10.1210/en.2009-0726
239. Huin C., Corriveau L., Bianchi A., Keller J. M., Collet P., Krémarik-Bouillaud P., Domenjoud L., Bécuwe P., Schohn H., Ménard D., Dauça M., Differential expression of peroxisome proliferator-activated receptors (PPARs) in the developing human fetal digestive tract. Journal of Histochemistry and Cytochemistry 2000 48 5 603 611 2-s2.0-17544387857 (Pubitemid 30233184)
240. Feng D., Zhang Y., Chen G., Cortical expression of peroxisome proliferator-activated receptor- α after human brain contusion. Journal of International Medical Research 2008 36 4 783 791 2-s2.0-52049083897
241. Jakobsen M. A., Petersen R. K., Kristiansen K., Lange M., Lillevang S. T., Peroxisome proliferator-activated receptor α δ γ 1 and γ 2 expressions are present in human monocyte-derived dendritic cells and modulate dendritic cell maturation by addition of subtype-specific ligands. Scandinavian Journal of Immunology 2006 63 5 330 337 2-s2.0-33646262056 10.1111/j.1365-3083.2006.01745.x
242. Bouwens M., Afman L. A., Müller M., Activation of peroxisome proliferator-activated receptor alpha in human peripheral blood mononuclear cells reveals an individual gene expression profile response. BMC Genomics 2008 9, article 262 2-s2.0-45849083190 10.1186/1471-2164-9-262 (Pubitemid 351876317)
243. Ding S. T., Schinckel A. P., Weber T. E., Mersmann H. J., Expression of porcine transcription factors and genes related to fatty acid metabolism in different tissues and genetic populations. Journal of Animal Science 2000 78 8 2127 2134 2-s2.0-0034242661
244. Barish G. D., Downes M., Alaynick W. A., Yu R. T., Ocampo C. B., Bookout A. L., Mangelsdorf D. J., Evans R. M., A nuclear receptor atlas: macrophage activation. Molecular Endocrinology 2005 19 10 2466 2477 2-s2.0-25444448223 10.1210/me.2004-0529 (Pubitemid 41362661)
245. Patsouris D., Mandard S., Voshol P. J., Escher P., Tan N. S., Havekes L. M., Koenig W., März W., Tafuri S., Wahli W., Müller M., Kersten S., PPAR α governs glycerol metabolism. Journal of Clinical Investigation 2004 114 1 94 103 2-s2.0-3242750659 10.1172/JCI200420468 (Pubitemid 39071648)
246. Hashimoto T., Cook W. S., Qi C., Yeldandi A. V., Reddy J. K., Rao M. S., Defect in peroxisome proliferator-activated receptor α -inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. Journal of Biological Chemistry 2000 275 37 28918 28928 2-s2.0-0034666132
247. Mohapatra S. K., Cole L. E., Evans C., Sobral B. W., Bassaganya-Riera J., Hontecillas R., Vogel S. N., Crasta O. R., Modulation of hepatic PPAR expression during Ft LVS LPS-induced protection from Francisella tularensis LVS infection. BMC Infectious Diseases 2010 10, article 10 2-s2.0-77349124242 10.1186/1471-2334-10-10
248. Fu M., Sun T., Bookout A. L., Downes M., Yu R. T., Evans R. M., Mangelsdorf D. J., A nuclear receptor atlas: 3T3-L1 adipogenesis. Molecular Endocrinology 2005 19 10 2437 2450 2-s2.0-25444504005 10.1210/me.2004-0539 (Pubitemid 41362659)
249. Vosper H., Patel L., Graham T. L., Khoudoli G. A., Hill A., Macphee C. H., Pinto I., Smith S. A., Suckling K. E., Wolf C. R., Palmer C. N. A., The peroxisome proliferator-activated receptor δ promotes lipid accumulation in human macrophages. Journal of Biological Chemistry 2001 276 47 44258 44265 2-s2.0-0035941270 10.1074/jbc.M108482200
250. Lord E., Murphy B. D., Desmarais J. A., Ledoux S., Beaudry D., Palin M. F., Modulation of peroxisome proliferator-activated receptor δ and γ transcripts in swine endometrial tissue during early gestation. Reproduction 2006 131 5 929 942 2-s2.0-33744483118 10.1530/rep.1.00657 (Pubitemid 43805436)
251. Guan Y., Zhang Y., Davis L., Breyer M. D., Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans. American Journal of Physiology 1997 273 6 F1013 F1022 2-s2.0-0031408955
252. Hall M. G., Quignodon L., Desvergne B., Peroxisome proliferator-activated receptor β / δ in the brain: facts and hypothesis. PPAR Research 2008 2008 10 780452 10.1155/2008/780452
253. Sundvold H., Brzozowska A., Lien S., Characterisation of bovine peroxisome proliferator-activated receptors γ 1 and γ 2: genetic mapping and differential expression of the two isoforms. Biochemical and Biophysical Research Communications 1997 239 3 857 861 2-s2.0-0031590465 10.1006/bbrc.1997.7564 (Pubitemid 27504192)
254. García-Rojas P., Antaramian A., González-Dávalos L., Villarroya F., Shimada A., Varela-Echavarría A., Mora O., Induction of peroxisomal proliferator-activated receptor γ and peroxisomal proliferator-activated receptor γ coactivator 1 by unsaturated fatty acids, retinoic acid, and carotenoids in preadipocytes obtained from bovine white adipose tissue. Journal of Animal Science 2010 88 5 1801 1808 2-s2.0-77951142010 10.2527/jas.2009-2579
255. Meng H., Li H., Wang Y. X., Characterization of tissue expression of peroxisome proliferator activated receptors in the chicken. Acta Genetica Sinica 2004 31 7 682 687 2-s2.0-3142757821 (Pubitemid 38937412)
256. Vidal-Puig A. J., Considine R. V., Jimenez-Liñan M., Werman A., Pories W. J., Caro J. F., Flier J. S., Peroxisome proliferator-activated receptor gene expression in human tissues: effects of obesity, weight loss, and regulation by insulin and glucocorticoids. Journal of Clinical Investigation 1997 99 10 2416 2422 2-s2.0-0030977450 (Pubitemid 27227719)
257. Fajas L., Auboeuf D., Raspé E., Schoonjans K., Lefebvre A. M., Saladin R., Najib J., Laville M., Fruchart J. C., Deeb S., Vidal-Puig A., Flier J., Briggs M. R., Staels B., Vidal H., Auwerx J., The organization, promoter analysis, and expression of the human PPAR γ gene. Journal of Biological Chemistry 1997 272 30 18779 18789 2-s2.0-0030835678 10.1074/jbc.272.30.18779 (Pubitemid 27318225)
258. Michael L. F., Lazar M. A., Mendelson C. R., Peroxisome proliferator-activated receptor γ 1 expression is induced during cyclic adenosine monophosphate-stimulated differentiation of alveolar type II pneumonocytes. Endocrinology 1997 138 9 3695 3703 2-s2.0-0030811061 10.1210/en.138.9.3695 (Pubitemid 27351918)
259. Rogue A., Renaud M. P., Claude N., Guillouzo A., Spire C., Comparative gene expression profiles induced by PPAR γ and PPAR α / γ agonists in rat hepatocytes. Toxicology and Applied Pharmacology 2011 254 1 18 31 2-s2.0-79957970349 10.1016/j.taap.2011.04.005
260. Kersten S., Mandard S., Tan N. S., Escher P., Metzger D., Chambon P., Gonzalez F. J., Desvergne B., Wahli W., Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. Journal of Biological Chemistry 2000 275 37 28488 28493 2-s2.0-0034666157
261. Lu M., Sarruf D. A., Talukdar S., Sharma S., Li P., Bandyopadhyay G., Nalbandian S., Fan W., Gayen J. R., Mahata S. K., Webster N. J., Schwartz M. W., Olefsky J. M., Brain PPAR- γ promotes obesity and is required for the insuling-sensitizing effect of thiazolidinediones. Nature Medicine 2011 17 5 618 622 2-s2.0-79955694276 10.1038/nm.2332
262. Ryan K. K., Li B., Grayson B. E., Matter E. K., Woods S. C., Seeley R. J., A role for central nervous system PPAR- γ in the regulation of energy balance. Nature Medicine 2011 17 5 623 626 2-s2.0-79955692835 10.1038/nm.2349